Antifungal agents versus placebo for preventing fungal infections in immunocompromised patients
Antifungal agents versus placebo for preventing fungal infections in immunocompromised patients
Cochrane Review
12 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Caries increment (surface index d3fs)
0 ppm F toothpaste |
-1.86 | - | - | Not assessed |
|
Caries increment (surface index d3mfs)
250 ppm F toothpaste |
-1.2 | - | - | Not assessed |
|
Caries increment (tooth index d3mft)
250 ppm F toothpaste |
-0.4 | - | - | Not assessed |
|
Proportion of children developing new caries
250 ppm F toothpaste |
0.92 | - | - | Not assessed |
|
Proportion developing new caries
440 ppm F toothpaste |
0.87 | - | - | Not assessed |
|
Adverse effects of toothpaste
0 ppm F toothpaste |
nan | - | - | Not assessed |
|
Caries increment (surface index D3(M)FS)
0 ppm F toothpaste |
nan | - | - | Not assessed |
|
Caries increment (tooth index D3(M)FT)
0 ppm F toothpaste |
nan | - | - | Not assessed |
|
Caries increment (surface index D3MFS)
0 ppm F toothpaste |
-0.53 | - | - | Not assessed |
|
Caries increment (tooth index D3MFT)
0 ppm F toothpaste |
-0.46 | - | - | Not assessed |
|
Proportion of adults developing new caries
0 ppm F toothpaste |
nan | - | - | Not assessed |
|
nan
nan |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD007868 |
| Outcomes: | 12 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
12